Definium Therapeutics, Inc. (DFTX)
Market Closed
17 Jul, 20:00
$
44. 29
+0.19
+0.4308%
$
5.01B Market Cap
- P/E Ratio
- Div Yield
1.49M Volume
- Eps
$ 44.1
Previous Close 
Want to track DFTX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Definium Therapeutics, Inc. (DFTX) Statistics
Valuation metrics
Market Cap 5.01B
Enterprise value 4.57B
Trailing P/E (ttm) -17.72
Forward P/E -
PEG ratio 0.23
Price/Sales (ttm) -
Price/Book (mrq) 17.28
Enterprise Value/Revenue -
Enterprise Value/EBITDA -20.54
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.49M
Average volume (90 days) 2.4M
Price summary
52-Week low 7.96
52-Week high 49.2
Beta -
50-Day moving average 31.12
200-Day moving average 19.6
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.59%
Return on equity -1.02%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -2.18
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 3.43
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 4.69%
Book value per share (mrq) 2.56
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
